NCT01503398View on ClinicalTrials.gov

Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Fasting
Interventions
DRUG

Olanzapine

Olanzapine Tablets, 5 mg

Trial Locations (1)

380061

Lambda Therapeutic Research Ltd.,, Ahmedabad

Sponsors
All Listed Sponsors
lead

Dr. Reddy's Laboratories Limited

INDUSTRY